JP2005503146A5 - - Google Patents

Download PDF

Info

Publication number
JP2005503146A5
JP2005503146A5 JP2003520762A JP2003520762A JP2005503146A5 JP 2005503146 A5 JP2005503146 A5 JP 2005503146A5 JP 2003520762 A JP2003520762 A JP 2003520762A JP 2003520762 A JP2003520762 A JP 2003520762A JP 2005503146 A5 JP2005503146 A5 JP 2005503146A5
Authority
JP
Japan
Prior art keywords
cell composition
mesenchymal
synovial fluid
mesenchymal cells
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003520762A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503146A (ja
Filing date
Publication date
Priority claimed from DE10139783A external-priority patent/DE10139783C1/de
Application filed filed Critical
Publication of JP2005503146A publication Critical patent/JP2005503146A/ja
Publication of JP2005503146A5 publication Critical patent/JP2005503146A5/ja
Pending legal-status Critical Current

Links

JP2003520762A 2001-08-14 2002-08-13 変形性関節症の治療に用いるための細胞組成物と、その製造方法 Pending JP2005503146A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10139783A DE10139783C1 (de) 2001-08-14 2001-08-14 Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung
PCT/EP2002/009080 WO2003015803A1 (de) 2001-08-14 2002-08-13 Zellzusammensetzungen zur behandlung von osteoarthrose, sowie verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
JP2005503146A JP2005503146A (ja) 2005-02-03
JP2005503146A5 true JP2005503146A5 (enExample) 2006-01-05

Family

ID=7695336

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003520762A Pending JP2005503146A (ja) 2001-08-14 2002-08-13 変形性関節症の治療に用いるための細胞組成物と、その製造方法

Country Status (5)

Country Link
US (1) US20040241144A1 (enExample)
EP (1) EP1418927A1 (enExample)
JP (1) JP2005503146A (enExample)
DE (1) DE10139783C1 (enExample)
WO (1) WO2003015803A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10333901A1 (de) * 2003-07-21 2005-03-10 Transtissue Technologies Gmbh Verwendung von Chemokinen zur Rekrutierung von humanen mesenchymalen Vorläuferzellen zur Regeneration von Gelenkdefekten
KR101598947B1 (ko) * 2004-09-24 2016-03-08 메소블라스트, 아이엔씨. 간엽 전구세포의 증식 및/또는 생존성 증강 방법
DE102005030614B4 (de) * 2005-06-30 2014-05-08 Biotissue Ag Zellfreies Transplantat, dessen Verwendung, Verfahren zu dessen Herstellung, dabei hergestellte Matrix mit Gel und Verfahren zur Herstellung dieser Matrix mit Gel
EP1957633B1 (en) 2005-10-13 2013-12-18 Anthrogenesis Corporation Immunomodulation using placental stem cells
US9598669B2 (en) 2005-12-29 2017-03-21 Anthrogenesis Corporation Composition for collecting placental stem cells and methods of using the composition
WO2007079184A2 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Co-culture of placental stem cells and stem cells from a second source
EP2471903B1 (en) 2005-12-29 2018-02-14 Anthrogenesis Corporation Placental stem cell populations
NZ571127A (en) 2006-03-07 2012-01-12 Geeta Shroff Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
US7993918B2 (en) 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
DE102006047346A1 (de) 2006-10-06 2008-04-10 Transtissue Technologies Gmbh Matrix-Gel-Transplantat ohne Zellen
JP2010518812A (ja) 2007-02-12 2010-06-03 アンスロジェネシス コーポレーション 接着性胎盤幹細胞由来の肝細胞および軟骨細胞、ならびにcd34+、cd45−胎盤幹細胞の濃縮細胞集団
PL2120977T3 (pl) 2007-02-12 2013-12-31 Anthrogenesis Corp Leczenie chorób zapalnych z zastosowaniem łożyskowych komórek macierzystych
US8263065B2 (en) 2007-09-28 2012-09-11 Anthrogenesis Corporation Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
DK2329012T3 (da) 2008-08-20 2020-08-24 Celularity Inc Behandling af slagtilfælde under anvendelse af isolerede placentaceller
EP3172963B1 (en) 2008-08-20 2019-02-06 Celularity, Inc. Improved cell composition and methods of making the same
DK2331109T3 (da) 2008-08-22 2013-09-08 Anthrogenesis Corp Fremgangsmåder og sammensætninger til behandling af knogledefekter med placentale cellepopulationer
RU2562154C2 (ru) 2008-11-19 2015-09-10 Антродженезис Корпорейшн Амниотические адгезивные клетки
KR20120115602A (ko) 2010-01-26 2012-10-18 안트로제네시스 코포레이션 태반 줄기 세포를 사용한 골 관련 암의 치료
PT2556145T (pt) 2010-04-07 2016-10-25 Anthrogenesis Corp Angiogénese usando células estaminais placentárias
EP2555783A1 (en) 2010-04-08 2013-02-13 Anthrogenesis Corporation Treatment of sarcoidosis using placental stem cells
KR20230096132A (ko) 2010-07-13 2023-06-29 셀룰래리티 인코포레이티드 천연 킬러 세포의 생성 방법
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
US9040035B2 (en) 2011-06-01 2015-05-26 Anthrogenesis Corporation Treatment of pain using placental stem cells
AU2012323963B2 (en) * 2011-10-13 2017-10-12 Solventum Intellectual Properties Company Stimulation of cartilage repair using reduced pressure treatment
CN103961373A (zh) * 2013-02-04 2014-08-06 西比曼生物科技(上海)有限公司 异体间质血管层细胞和异体间充质祖细胞在预防或治疗骨性关节炎中的应用
JP2016506968A (ja) 2013-02-05 2016-03-07 アントフロゲネシス コーポレーション 胎盤由来のナチュラルキラー細胞
US20210047621A1 (en) 2018-03-12 2021-02-18 Universidade Do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
CN108815187A (zh) * 2018-07-20 2018-11-16 深圳市第二人民医院 一种包含人关节液外泌体的制剂及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
CA2288690A1 (en) * 1997-05-13 1998-11-19 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration using human mesenchymal stem cells
US6835377B2 (en) * 1998-05-13 2004-12-28 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration
DE60143517D1 (de) * 2000-04-25 2011-01-05 Osiris Therapeutics Inc Wiederherstellung der gelenken mit mesenchymalen stammzellen
US6800298B1 (en) * 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition

Similar Documents

Publication Publication Date Title
JP2005503146A5 (enExample)
Shanti et al. Adult mesenchymal stem cells: biological properties, characteristics, and applications in maxillofacial surgery
US7887843B2 (en) Method for in vitro production of three-dimensional vital cartilage tissue and use thereof as transplant material
AU731827B2 (en) Production of cartilage tissue using cells isolated from Wharton's jelly
US20040241144A1 (en) Cell compositions for use in the treatment of osteo-arthrosis, and methods for producing the same
Kiernan et al. Endochondral ossification: recapitulating bone development for bone defect repair
Freyria et al. Optimization of dynamic culture conditions: effects on biosynthetic activities of chondrocytes grown in collagen sponges
JPS59192364A (ja) 軟骨および骨の修復方法
EP1792980B1 (de) Kollagenbiomatrix und Verfahren zu ihrer Herstellung
Nussenbaum et al. Tissue engineering: the current status of this futuristic modality in head neck reconstruction
Meng et al. Stem cell homing in periodontal tissue regeneration
Polak et al. Gene therapy progress and prospects: in tissue engineering
KR20200000823A (ko) 인간 유도 만능 줄기세포로부터 연골세포의 펠렛을 제조하는 방법 및 이의 용도
Hoben et al. Meniscal repair with fibrocartilage engineering
Leng et al. Reconstruct large osteochondral defects of the knee with hIGF-1 gene enhanced Mosaicplasty
Canciani et al. Human adipose-derived stem cells on rapid prototyped three-dimensional hydroxyapatite/beta-tricalcium phosphate scaffold
Choi et al. Chondrogenesis of human periosteum-derived progenitor cells in atelocollagen
Sándor et al. Combining adipose-derived stem cells, resorbable scaffolds and growth factors: An overview of tissue engineering
CN105412986B (zh) 小肠黏膜下层载药补片及其制备方法和应用
Salinas et al. The functionality and translatability of neocartilage constructs are improved with the combination of fluid‐induced shear stress and bioactive factors
Wang et al. High quality repair of osteochondral defects in rats using the extracellular matrix of antler stem cells
Cheung In vitro cartilage formation on porous hydroxyapatite ceramic granules
RU2545993C2 (ru) Способ восстановления костных дефектов трубчатых костей критической величины
Tong et al. Novel scaffold containing transforming growth factor-β1 DNA for cartilage tissue engineering
Jessop et al. 3D bioprinting cartilage